The New York Times reports that “AstraZeneca is adding a new heart warning to the labels of Seroquel [quetiapine], its blockbuster antipsychotic drug, at the request of the Food and Drug Administration, company and agency officials said on Monday.” The new “label, posted without fanfare last week on the FDA website, says Seroquel and extended-release Seroquel XR ‘should be avoided’ in combination with at least 12 other medicines linked to a heart arrhythmia” called prolongation of the QT interval. The revised “label also raises caution about use by the aged and people with heart disease.”
From the American Association for Justice news release.
